Jun. 27 at 9:19 PM
Reposting this from @Hoppanin because if you’re not prepared for high risk @Biotech_Beast or @SmallCapValueTrading then you should buy the S&P500 or QQQM. This is biotech. High risk, higher rewards on multiple levels 🧘♂️
Sick of wannabe bulls complaining about a dip from
$40 to
$32. On a biotech stock.
$ALT dropped 60% yesterday on a positive readout in MASH because 5 patients in the placebo appeared to outperform historical baselines. Instead of complaining like a baby, I reviewed the data and decided to buy more.
$NUVB has dropped 20% since it received an early approval in ROS1+ NSCLC and, yes, still buying.
I own a lot of
$TNXP ahead of the PDUFA in 7 weeks and am Happy to keep buying shares here. 🚀
Also adding
$IMRX (pancreatic cancer) &
$TLSA (Alzheimer’s).
Good luck Biotech Bulls! @sushitime here 😋
